# Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

> clinical trial · VERIFIED · 2026-07-13

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Muscle Invasive Bladder Urothelial Carcinoma

- Company: National Cancer Institute (NCI)
- Sector: Muscle Invasive Bladder Urothelial Carcinoma
- Primary source: https://clinicaltrials.gov/study/NCT07061964

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.